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1. Introduction 
Tzagoloff and Meagher have isolated a purified, 
oligomycin-sensitive form of the mitochondrial ATPase 
from yeast submitochondrial particles (SMP) with 
Triton X-100 [l] . In this paper we describe the 
properties of a similar preparation from beef heart 
SMP (Triton-ATPase). This ATPase activity is inhibited 
by oligomycin, peliomycin, ossamycin and aurovertin 
B. However, N,N’-dicyclohexylcarbodiimide (DCCD) 
is without effect and low concentrations of venturi- 
cidin A stimulate the ATPase activity in a markedly 
time-dependent fashion. The results suggest a 
functional separation of the sites of inhibitory action 
of DCCD, oligomycin and venturicidin A and reveal 
a novel venturicidin stimulatory mechanism. 
2. Materials and methods 
Beef heart SMP were prepared by the method of 
Hansen and Smith [2]. ATPase activities were 
measured at 30°C and pH 8.2 [3]. 
The Triton-ATPase was prepared as follows. SMP 
suspended in 0.25 M sucrose and 10 mM tris sulphate, 
pH 7.7,O”C, at a concentration of about 15 mg of 
protein/ml were mixed with an appropriate volume 
of 10% (w/v) Triton X-l 00, adjusted to pH 7.7, to 
give 1 part of Triton to 2.5 parts of protein by weight 
[ 11. The supernatant fraction obtained after centri- 
fugation at 100 000 g for 1 hr was used directly. It 
could be stored for several days at 4°C or frozen at 
-15°C without apparent change in specific activity 
or response to inhibitors. Venturicidin A, aurovertin 
B and [’ 4 C] DCCD were purified samples from this 
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laboratory [4--61. Peliomycin, ossamycin and 
triethyltin sulphate were the kind gifts of Drug 
Research and Chemotherapy, National Cancer 
Institute, USA and Dr D. E. Griffiths, University of 
Warwick, UK. 
3. Results and discussion 
The specific activity of the Triton-ATPase was lower 
than that of the starting SMP. This contrasts with the 
preparation from yeast at a similar stage of purification 
which had an an increased specific activity [l] . Whilst 
the beef heart Triton-ATPase was inhibited by low 
concentrations of oligomycin, it was somewhat less 
sensitive than the original SMP ATPase (see table 1) 
[7]. Peliomycin and ossamycin, which have a similar 
mode of action to oligomycin [8], and aurovertin B 
which inhibits the ATPase molecule directly [9], also 
inhibited the Triton-ATPase activity to a lesser extent 
than they inhibited the membrane-bound ATPase 
(table 1). The sensitivity to triethyltin sulphate was 
reduced in the Triton-ATPase in a somewhat variable 
manner. This inhibition by oligomycin, peliomycin 
and ossamycin implies that there is neither appreciable 
alternation in the binding site(s) for these inhibitors 
which is located on the membrane and not on the 
ATPase molecule itself [lo] , nor in the mechanism 
of the interaction between the binding site(s) and 
the ATPase molecule. 
DCCD is an irreversible inhibitor of the membrane- 
bound ATPase [ 1 l] being covalently bound to a 
membrane proteolipid [12]. The specific radioactivity 
of the Triton-ATPase prepared from SMP previously 
inhibited with [14C] DCCD showed that the DCCD 
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Table 1 
Sensitivity of the Triton-ATPase to inhibitors 
May 1975 
SMP Triton-ATPase 
Inhibitor ATPase Inhibitor % ATPase Inhibitor % % 
activity concen- inhibition activity concentration Inhibition Stimulation 
&mol . min - ’ tration (pm01 mind’ (nmol mg of 
.mgof (nmol . mg .mgof protein) 
protein _ ’ ) of protein _ I ) protein _ I ) 
_ 
None 3.04 _ _ 1.14 - _ _ 
Oligomycin 0.19 4.6 94 0.28 6.2 75 _ 
Peliomycin 0.34 3.1 89 0.22 6.2 81 - 
Ossamycin 0.47 3.9 85 0.26 6.2 77 _ 
Triethyltin 
sulphate 0.27 34 91 0.55 17 52 _ 
Venturicidin A 0.17 3.4 95 2.97 31 _ 162 
Aurovertin B 0.44 29 86 0.40 35 65 - 
Either alcoholic solutions of inhibitors or alcohol were added to the SMP or Triton-ATPase in the ATPase assay mix and 
preincubated for 5 min at 30°C. The assays were initiated by addition of ATP. It was assumed that the mol. wts of 
peliomycin and ossamycin were the same as for oligomycin B, 804 [ 191. 
binding component was solubilised more efficiently 
than was the ATPase activity, which was no longer 
inhibited (table 2). Thus, Triton X- 100 solubilisation 
of the ATPase disrupts the interaction of the ATPase 
molecule and the DCCDbinding site. 
Venturicidin A is an inhibitor which has some 
functional similarities to oligomycin [8] but 
biochemical [4,8,13] and genetic studies [14,15] 
have suggested a different mechanism of action. It 
can be seen from table 1 that venturicidin A inhibited 
the SMP ATPase activity but relatively low concen- 
trations stimulated the Triton-ATPase activity 2.5 
fold (fig. 1). This stimulation was time-dependent. 
Whereas oligomycin inhibition was complete by 2 min, 
Table 2 
The effect of Triton X-100 solubilisation on the ATPase activity of 
[r ‘C] DCCD-inhibited beef heart SMP. 
Control SMP [r4C]DCCD-treated SMP 
Treatment ATPase activity ATPase activity [‘4C]DCCD 
bmole . min - I . bmol . min-’ . bound (nmol . 
mg of protein- ’ ) mg of protein - I ) mg of protein- ’ ) 
Before detergent 3.3 0.1 1.0 
Triton ATPase 0.6 0.8 1.7 
Washed SMP were treated overnight at 0°C with methanol containing 1 nmol 
of DCCD mg of protein“ (3.1 Ci . mol-’ ) or with methanol in the control. 
After centrifugation at 100 000 g, the pellets were resuspended in 0.25 M 
sucrose. 10 mM Tris sulphate buffer, pH 7.7, and their ATPase activities and 
radioactivity were measured. The Triton-ATPase preparations were made and 
their ATPase activities and radioactivity were measured. 
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Fig.1. Stimulation of the T&on-ATPase by venturicidin A. 
Aliquots of venturicidin A in methanol (or methanol for 
controls) were preincubated with the Triton-ATPase in the 
ATPase assay medium for 5 min at 30°C. Initial ATPase 
activity was 0.23 pmol * min-’ . mg of protein-‘. 
the ATPase stimulation appeared to be increasing after 
2.5 hr of incubation of the Triton-ATPase with 
venturicidin A (fig.2). Treatment of the Triton-ATPase 
with a mixture of oligomycin and venturicidin A 
caused a comparable inhibition to that with oligomycin 
alone, even after 1.5 hr (fig.2), which shows that 
venturicidin is unable to relieve oligomycin inhibition 
in this case. The explanation for this oligomycin 
‘dominance’ is uncertain. 
The Triton-ATPase from trypsin-treated SMP [ 161 
which are deficient in the endogenous inhibitor [ 171 
was still stimulated by venturicidin A (data not shown). 
This excludes a mechanism for the stimulation due to 
the displacement of the inhibitor protein by venturici- 
din. Venturicidin A in the presence of Triton X-100 had 
no effect on the activity of the soluble ATPase 
prepared by chloroform treatment of beef heart SMP 
[ 181 even after prolonged incubation at 3O”C, which 
rules out a direct interaction with the ATPase 
molecule itself. 
The present results show that Triton treatment of 
the mitochondrial membrane-bound ATPase modifies 
its reponse to some inhibitory compounds. Thus, 
DCCD covalently bound to its site of action does not 
Venturicidin AI 
Q 
f n -m -u 
c! 
Oligomycin 
” . 0 
Oligomycin + Venturicidin , 
0 50 100 150 
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Fig.2. Time dependence of the effects of inhibitors on the 
Triton-ATPase. The Triton-ATPase (0.32 mg of protein in 
200 ~1) was mixed with (0) 3 ~1 of ethanol and 1 ~.rl of 
methanol; (o) 3 ~1 of ethanolic oligomycin (1.0 mg * ml-’ ); 
(a) 1 ~1 of methanolic venturicidin A (3.3 mg * ml-‘); 
(0) 4 ~1 of previously mixed 3: 1 oligomycin and venturicidin 
A solutions, and incubated at 30°C. Aliquots (25 ~1) were 
extracted and assayed for ATPase activity at the times 
specified. 
exert an inhibitory effect on the ATPase in the presence 
of Triton. The venturicidin site(s) is also modified 
such that the functional effect of venturicidin is to 
stimulate rather than to inhibit the Triton-ATPase. 
This could be due to either; (1) a complete dissoci- 
ation of the interaction of the inhibitory venturicidin 
site with the ATPase, enabling a stimulatory venturi- 
cidin site to manifest itself, or (2) the conversion of 
an inhibitory venturicidin binding site to a stimulatory 
site, or (3) an effect of Triton on some other hypo- 
thetical component which normally mediates the 
inhibitory effects of venturicidin, such that the 
binding of venturicidin causes a stimulation rather 
than inhibition. 
It is now evident that mitochondrial ATPase 
activity can be both stimulated (present results) and 
inhibited by the interaction of small molecules with 
membrane components, which can then interact with 
the ATPase molecule. This could be the basis for a 
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fine control mechanism of the ATPase activity, 
assuming that there are naturally occuring effecters in 
the membrane with effects analogous to those of the 
antibiotics reported here. Such a mechanism would 
be additional to the postulated regularory role of 
the inhibitor protein [ 171. 
The results emphasise differences both between 
the Triton-ATPase preparations from beef heart and 
from yeast SMP, and the Triton-solubilised and the 
membrane-bound ATPases. 
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